Expansion Cohorts in Early Development of Anticancer Agents
February 21, 2019 - Toronto ON CA
Xtalks
fbonilla@xtalks.com
Phone: 1 416.977.6555
Join this webinar to learn about: The recent literature related to the use and design features of phase 1/2 trials and those with expansion cohorts The key points in the recent FDA draft guidance for industry The statistical caveats to have in mind when designing phase 1 trials with expansion cohorts, including early consideration of randomization and issues related to sample size calculation